These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11460205)

  • 1. Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain.
    Anelli A; Lima CA; Younes RN; Gross JL; Fogarolli R
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(2):53-8. PubMed ID: 11460205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
    Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
    J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
    Maneechawakajorn J; Hathaisanguan S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non-Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy.
    Goldman JW; Shi P; Reck M; Paz-Ares L; Koustenis A; Hurt KC
    Clin Lung Cancer; 2016 Jan; 17(1):80-4. PubMed ID: 26432508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
    Paz-Ares L; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
    Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
    Ganz PA; Figlin RA; Haskell CM; La Soto N; Siau J
    Cancer; 1989 Apr; 63(7):1271-8. PubMed ID: 2465815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.
    Helsing M; Bergman B; Thaning L; Hero U
    Eur J Cancer; 1998 Jun; 34(7):1036-44. PubMed ID: 9849452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
    Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
    J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.
    Ranson M; Davidson N; Nicolson M; Falk S; Carmichael J; Lopez P; Anderson H; Gustafson N; Jeynes A; Gallant G; Washington T; Thatcher N
    J Natl Cancer Inst; 2000 Jul; 92(13):1074-80. PubMed ID: 10880550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
    Spiro SG; Rudd RM; Souhami RL; Brown J; Fairlamb DJ; Gower NH; Maslove L; Milroy R; Napp V; Parmar MK; Peake MD; Stephens RJ; Thorpe H; Waller DA; West P;
    Thorax; 2004 Oct; 59(10):828-36. PubMed ID: 15454647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy.
    Thongprasert S; Sanguanmitra P; Juthapan W; Clinch J
    Lung Cancer; 1999 Apr; 24(1):17-24. PubMed ID: 10403690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
    Cellerino R; Tummarello D; Guidi F; Isidori P; Raspugli M; Biscottini B; Fatati G
    J Clin Oncol; 1991 Aug; 9(8):1453-61. PubMed ID: 1649267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study].
    Quoix E; Dietemann A; Charbonneau J; Boutin C; Meurice JC; Orlando JP; Ducolone A; Pauli G; Roegel E
    Bull Cancer; 1991; 78(4):341-6. PubMed ID: 1650266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus best supportive care for advanced non-small-cell lung cancer.
    Abang AM
    Am J Health Syst Pharm; 1996 Dec; 53(24):2980-4. PubMed ID: 8974162
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.
    Pujol JL; Paz-Ares L; de Marinis F; Dediu M; Thomas M; Bidoli P; Corral J; San Antonio B; Chouaki N; John W; Zimmermann A; Visseren-Grul C; Gridelli C
    Clin Lung Cancer; 2014 Nov; 15(6):418-25. PubMed ID: 25104617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
    Garon EB; Ciuleanu TE; Arrieta O; Prabhash K; Syrigos KN; Goksel T; Park K; Gorbunova V; Kowalyszyn RD; Pikiel J; Czyzewicz G; Orlov SV; Lewanski CR; Thomas M; Bidoli P; Dakhil S; Gans S; Kim JH; Grigorescu A; Karaseva N; Reck M; Cappuzzo F; Alexandris E; Sashegyi A; Yurasov S; Pérol M
    Lancet; 2014 Aug; 384(9944):665-73. PubMed ID: 24933332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
    Dancey J; Shepherd FA; Gralla RJ; Kim YS
    Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.